Skip to content

Glycohemoglobin-Skreen Test Kit

by Eppendorf-Brinkmann, Inc. 510(k)

Active United States

510(k) K780819

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK780819 Date7 Nov 1978ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
LCP
Device Class
Class II
Regulation
21 CFR Part 864.7470
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Glycohemoglobin-Skreen Test Kit is an assay for glycosylated hemoglobin used in hematology. It is a diagnostic test designed to measure levels of glycosylated hemoglobin in blood samples.

Supplied as a test kit, it is intended for use in clinical laboratory settings. The device received FDA 510(k) clearance (K780819) on November 7, 1978, and is classified as a Class II medical device under regulation number 864.7470. It is manufactured by Eppendorf-Brinkmann, Inc. and distributed in the United States.

Other devices from Eppendorf-Brinkmann, Inc.

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Glycohemoglobin-Skreen Test Kit used for?

    The Glycohemoglobin-Skreen Test Kit is an assay designed to measure levels of glycosylated hemoglobin in blood samples. It is used in hematology to assess long-term blood glucose control, providing diagnostic information for conditions such as diabetes.

  • How is the Glycohemoglobin-Skreen Test Kit supplied and where is it intended for use?

    The device is supplied as a test kit and is intended for use in clinical laboratory settings. It is distributed in the United States by Eppendorf-Brinkmann, Inc. for professional diagnostic testing of blood samples.

  • Is the Glycohemoglobin-Skreen Test Kit a single-use or reusable device?

    The Glycohemoglobin-Skreen Test Kit is supplied as a test kit, which implies it contains reagents and components for performing the assay. Based on its description as an in vitro diagnostic test kit, it is intended for single-use per test, though the kit may allow multiple tests depending on the number of tests included.

  • What regulatory pathway was used for the Glycohemoglobin-Skreen Test Kit and what is its classification?

    The device received FDA 510(k) clearance under submission K780819 on November 7, 1978. It is classified as a Class II medical device under regulation number 864.7470, with product code LCP, and was found substantially equivalent to a predicate device.

  • What are the storage and handling requirements for the Glycohemoglobin-Skreen Test Kit?

    The device data does not specify storage conditions, temperature requirements, or shelf life for the Glycohemoglobin-Skreen Test Kit. Users should consult the manufacturer’s labeling or instructions for use for proper storage and handling guidance.